Gaby Murphy took on the role of Managing Director at EMD Serono Canada in November 2015. He is responsible for the Canadian business sector and works to ensure patients across Canada can benefit from the organization’s innovative therapies in oncology, neurodegenerative diseases, fertility and endocrinology. Gaby has more than 20 years of leadership experience in biopharmaceuticals, with significant knowledge in multiple sclerosis (MS) therapies.
Gaby first joined EMD Serono as National Sales Director in 2000, helping to grow the company’s MS portfolio for the next six years. In 2007, he moved to Novartis Canada, where he built the portfolios of several therapeutic areas, including cardiovascular and neurodegenerative diseases. In 2012, Gaby became Novartis’s Regional Neuroscience Head (Latin America and Canada) and championed treatments for MS, Parkinson’s and Alzheimer’s diseases. Gaby then worked as the Business Lead, Virology with Bristol Myers Squibb. In 2015, Gaby rejoined EMD Serono as the Head of the Neurodegenerative Diseases Business Unit.
Gaby holds a Bachelor of Science in Biology with a minor in Economics from the Université du Québec à Montréal.